DE69919597D1 - Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung - Google Patents

Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung

Info

Publication number
DE69919597D1
DE69919597D1 DE69919597T DE69919597T DE69919597D1 DE 69919597 D1 DE69919597 D1 DE 69919597D1 DE 69919597 T DE69919597 T DE 69919597T DE 69919597 T DE69919597 T DE 69919597T DE 69919597 D1 DE69919597 D1 DE 69919597D1
Authority
DE
Germany
Prior art keywords
formulations containing
topical formulations
skin penetration
containing skin
penetration agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69919597T
Other languages
English (en)
Other versions
DE69919597T2 (de
Inventor
Rajaram Vaidyanathan
M Vo
N Manning
Geoffrey Allan
A Helmy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Echo Therapeutics Inc
Original Assignee
DURHAM PHARMACEUTICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DURHAM PHARMACEUTICALS Ltd filed Critical DURHAM PHARMACEUTICALS Ltd
Application granted granted Critical
Publication of DE69919597D1 publication Critical patent/DE69919597D1/de
Publication of DE69919597T2 publication Critical patent/DE69919597T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69919597T 1999-06-25 1999-09-28 Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung Expired - Lifetime DE69919597T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14075699P 1999-06-25 1999-06-25
US140756P 1999-06-25
PCT/US1999/022313 WO2001000139A1 (en) 1999-06-25 1999-09-28 Topical formulations comprising skin penetration agents and the use thereof

Publications (2)

Publication Number Publication Date
DE69919597D1 true DE69919597D1 (de) 2004-09-23
DE69919597T2 DE69919597T2 (de) 2005-07-14

Family

ID=22492675

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919597T Expired - Lifetime DE69919597T2 (de) 1999-06-25 1999-09-28 Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung

Country Status (15)

Country Link
US (1) US6271219B2 (de)
EP (1) EP1194109B1 (de)
JP (1) JP2003506462A (de)
KR (1) KR100623534B1 (de)
AT (1) ATE273682T1 (de)
AU (1) AU769079B2 (de)
BR (1) BR9917389B1 (de)
CA (1) CA2376850C (de)
DE (1) DE69919597T2 (de)
DK (1) DK1194109T3 (de)
ES (1) ES2224755T3 (de)
MX (1) MXPA01013460A (de)
NZ (1) NZ516765A (de)
PT (1) PT1194109E (de)
WO (1) WO2001000139A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
JP2006502213A (ja) 2002-10-10 2006-01-19 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 脂肪族アルコール類の塩基性エステルおよび抗炎症薬または免疫調整薬としての使用
US20050101605A1 (en) * 2003-11-07 2005-05-12 Ahmed Salah U. Oral liquid formulations of methotrexate
CA2586815A1 (en) * 2004-11-29 2006-06-01 Ambria Dermatology Ab A composition comprising at least 3 different diols
WO2008106092A1 (en) 2007-02-26 2008-09-04 Yeda Research And Development Co. Ltd. Enantiomers of amino-phenyl-acetic acid octadec- 9- (z) enyl ester, their salts and their uses
KR100987121B1 (ko) * 2010-08-12 2010-10-12 연세대학교 산학협력단 창문닦기로봇
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US8853189B2 (en) 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols
CN105263474A (zh) * 2013-06-03 2016-01-20 托马有限公司 皮质类固醇组合物
CN104161721A (zh) * 2014-07-14 2014-11-26 湖北博康医药科技有限公司 一种用于治疗皮肤病的蛇王药剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE843140A (fr) 1975-06-19 1976-10-18 Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4552872A (en) 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4537776A (en) 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4886783A (en) 1986-01-31 1989-12-12 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
JPH0676328B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイドクリ−ム製剤
ATE104554T1 (de) * 1990-01-10 1994-05-15 Hoffmann La Roche Topische praeparate.
JP3207212B2 (ja) * 1991-03-01 2001-09-10 久光製薬株式会社 吸収促進剤およびこれを含有する外用剤
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
JPH06219947A (ja) * 1993-01-26 1994-08-09 Kinki Univ 経皮投与製剤
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
EP0971662A1 (de) * 1996-10-30 2000-01-19 TheraTech, Inc. Fettsäureester von glycolsäure und deren salze als penetrationsverstärker

Also Published As

Publication number Publication date
ATE273682T1 (de) 2004-09-15
US20010001790A1 (en) 2001-05-24
EP1194109A4 (de) 2003-01-15
KR20020038595A (ko) 2002-05-23
AU769079B2 (en) 2004-01-15
AU6060799A (en) 2001-01-31
NZ516765A (en) 2003-04-29
KR100623534B1 (ko) 2006-09-18
DE69919597T2 (de) 2005-07-14
WO2001000139A1 (en) 2001-01-04
CA2376850C (en) 2009-11-17
ES2224755T3 (es) 2005-03-01
JP2003506462A (ja) 2003-02-18
PT1194109E (pt) 2004-12-31
EP1194109B1 (de) 2004-08-18
EP1194109A1 (de) 2002-04-10
BR9917389B1 (pt) 2013-04-24
US6271219B2 (en) 2001-08-07
BR9917389A (pt) 2002-03-05
CA2376850A1 (en) 2001-01-04
DK1194109T3 (da) 2004-10-25
MXPA01013460A (es) 2003-09-04

Similar Documents

Publication Publication Date Title
CA1146070A (en) Topical triethylenetetramine-containing pharmaceutical compositions and methods of use
PE20001032A1 (es) Composiciones y metodos para tratar enfermedades pulmonares
CA1307207C (en) Steroid lotion
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
ATE323473T1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
DE69520768D1 (de) Pharmazeutische Zubereitungen, die Fluoxetin enthalten
ATE125445T1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
BR0204596A (pt) Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada
DK1392329T3 (da) Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom
SE9900961D0 (sv) Novel compounds
DE69919597D1 (de) Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ATE358474T1 (de) Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
SE9602644D0 (sv) New use
AR022017A1 (es) Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica
IE810489L (en) Composition for topical application
GEP20043231B (en) Resorcinol Composition
JP2016501236A (ja) 炎症性皮膚状態の予防および治療のための方法
BR9608721A (pt) Composição farmacêutica, e, processo para tratar inflamação
KR20000050667A (ko) 피부 미백 및 피부 질환 치료를 위한 조성물
IT1257884B (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ECHO THERAPEUTICS,INC., FRANKLIN, MASS., US